Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06892275 · ClinicalTrials.gov registry record · NA
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
A NA study of Magnetic Resonance Imaging and Breast Neoplasm Female, sponsored by Georgetown University.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06892275: Recruiting NA study of Magnetic Resonance Imaging and Breast Neoplasm Female, sponsored by Georgetown University.
NCT06892275 is a NA study of Magnetic Resonance Imaging and Breast Neoplasm Female that is actively recruiting participants, run by Georgetown University. The registered enrollment target is 80 participants, below the 154-participant average among 20 other Magnetic Resonance Imaging trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06892275, a NA study of Magnetic Resonance Imaging and Breast Neoplasm Female, is actively recruiting participants, sponsored by Georgetown University.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the impact of a multilevel decision support intervention on informed decisions about breast MRI among high-risk Black and Latina women. Participants (N=80) will be randomized to (1) enhanced usual care (risk assessment + referral to nurse practitioner) or (2) decision support (enhanced usual care + decision aid). Assessments will take place at baseline (T0) and 1-month post-intervention (T1). The primary outcome is informed decisions about breast MRI at T1.
Primary Outcome
According to the Multidimensional Measure of Informed Choice, an informed decision is made with adequate knowledge and consistent with the respondent's preferences. Thus, two groups are classified as having made an informed decision: (1) those with adequate MRI knowledge, whose preferences align with screening with mammogram + MRI, and who intend to undergo MRI; and (2) those with adequate MRI knowledge, whose preferences align with screening with mammogram only, and who do not intend to undergo
Conditions Studied
Interventions
- BEHAVIORAL Enhanced Usual Care
- BEHAVIORAL Decision Support
Study Locations (1)
District of Columbia
- Georgetown University - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-06-01 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT06892275 shows while recruiting
NCT06892275 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 154-participant average among 20 other Magnetic Resonance Imaging trials with a reported enrollment target (48% lower).
The record links to 4 conditions, with Magnetic Resonance Imaging appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.
NCT06892275 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT06892275 about?
NCT06892275 is a clinical study titled "The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI". The purpose of this study is to test the impact of a multilevel decision support intervention on informed decisions about breast MRI among high-risk Black and Latina women. Participants (N=80) will be randomized to (1) enhanced usual care (risk assessment + referral to nurse practitioner) or (2) dec...
What is the current status of trial NCT06892275?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-06-01. Estimated completion is 2027-12.
What conditions does trial NCT06892275 study?
This clinical trial studies the following conditions: Magnetic Resonance Imaging, Breast Neoplasm Female, Early Detection of Cancer, Hereditary Breast and Ovarian Cancer Syndrome.
What interventions are being tested in trial NCT06892275?
The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), Decision Support (BEHAVIORAL).
Who is sponsoring clinical trial NCT06892275?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06892275 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Magnetic Resonance Imaging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06892275's enrollment target sits among peer trials
80 10th of 20 higher than 10 of 20 other Magnetic Resonance Imaging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Magnetic Resonance Imaging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort
RECRUITING · NA
-
Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0
RECRUITING · NA
-
Serial MRI Scans During Radiation Therapy
RECRUITING · NA
-
Brain Stimulation for Concussion
ACTIVE NOT RECRUITING · NA
-
Brain Blood Flow Responses During Exercise
ACTIVE NOT RECRUITING · NA
-
Integrative Medicine in Pain Management in Sickle Cell Disease
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI